[144] Gevo, Inc. SEC Filing

Rhea-AI Filing Summary

Insider sale notice for Gevo, Inc. (GEVO): The filing reports a proposed sale of 1,731 shares of common stock through Stifel Nicolaus on or about 09/04/2025 with an aggregate market value of $2,821. Those shares were acquired as restricted stock units on 09/03/2025 and payment was in cash. The filer previously sold 57,651 shares on 08/20/2025 for $93,942 and 5,738 shares on 08/05/2025 for $7,061. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Compliance with Rule 144: The filer provides required details including broker, acquisition type (RSUs), prior sales, and certification about material non-public information.
• Transparency on origin of shares: Shares to be sold were granted as restricted stock units, clarifying they are issuer-originated and recently vested.

Negative

• Concentrated recent selling: The insider sold 63,389 shares in the past month and proposes additional sales, which could be viewed negatively by some investors.
• Potential governance question: The filing does not state a 10b5-1 trading plan adoption date, increasing questions about the timing of multiple sales.

Insights

Securities Analyst

TL;DR: Insider selling of recently vested RSUs and prior sizable dispositions; likely routine liquidity rather than a company-specific signal.

The filing discloses a small proposed sale of 1,731 shares derived from restricted stock units vested one day prior, with cash proceeds expected. Recent prior sales total 63,389 shares for roughly $101,003, indicating the insider has been monetizing a material number of shares over the past month. While insider sales can raise questions, the current notice documents compliance with Rule 144 and shows the shares originated from issuer-granted RSUs rather than open-market purchases. For investors, this is a transparency item rather than a definitive indicator of company performance.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; recurring sales warrant monitoring of insider trading patterns.

The form correctly lists acquisition dates, nature of acquisition (RSUs), prior sales, broker details, and the seller's certification about material non-public information. From a governance perspective, multiple sales within a short period increase scrutiny on whether a formal trading plan exists, though none is referenced on the form. The filing strengthens transparency but suggests stakeholders may want to review insider ownership trends and any disclosed trading plans in proxy or other filings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	1731	2821.00	239562995	09/04/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/03/2025	Restricted Stock Units	Issuer			6611	09/04/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Leke Agiri 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/20/2025	57651	93942.00
Leke Agiri 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/05/2025	5738	7061.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares of GEVO are proposed for sale in this Form 144?

The notice proposes sale of 1,731 shares of Gevo common stock through Stifel Nicolaus with an aggregate market value of $2,821.

How were the shares being sold acquired?

The shares were acquired as restricted stock units (RSUs) on 09/03/2025 and payment method listed is cash.

Has the filer sold other GEVO shares recently?

Yes. The filer sold 57,651 shares on 08/20/2025 for $93,942 and 5,738 shares on 08/05/2025 for $7,061.

Through which broker will the proposed sale occur?

The broker named is Stifel Nicolaus & Company Inc located in St. Louis, and the filing lists Nasdaq as the exchange.

Does the filing indicate any undisclosed material information about GEVO?

The seller certifies they are not aware of any material adverse information that has not been publicly disclosed.